Skip to main content
MedPathMedPath Home
Clinical Trials/NCT00537901
NCT00537901
Completed
Not Applicable

First-Line Bevacizumab and Chemotherapy in Metastatic Cancer of the Colon or Rectum - International Study

King Faisal Specialist Hospital & Research Center0 sites100 target enrollmentOctober 2007
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsColonic NeoplasmsRectal Neoplasms
DrugsBevacizumab

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Colonic Neoplasms
Sponsor
King Faisal Specialist Hospital & Research Center
Enrollment
100
Primary Endpoint
Effectiveness
Status
Completed
Last Updated
10 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

First-Line Bevacizumab and Chemotherapy in Metastatic Cancer of the Colon or Rectum

Registry
clinicaltrials.gov
Start Date
October 2007
End Date
October 2013
Last Updated
10 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Dr. Naeem A. Chaudhri

Principal Investigator

King Faisal Specialist Hospital & Research Center

Eligibility Criteria

Inclusion Criteria

  • •Patients with metastatic cancer of colon or rectum

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Effectiveness

Time Frame: overall

Secondary Outcomes

  • Quality of life(overall)

Similar Trials

Active, not recruiting
Not Applicable
First-line Bevacizumab and Chemotherapy in Metastatic Cancer of the Colon or Rectum. An Expanded Access Program.metastatic colo-rectal carcinomaMedDRA version: 6.1Level: PTClassification code 10061045
EUCTR2004-000315-26-ITROCHE1,500
Active, not recruiting
Phase 1
First-line Bevacizumab and Chemotherapy in Metastatic Cancer of the Colon or Rectum. An Expanded Access Program. - First BEATMetastatic cancer of the colon or rectum.
EUCTR2004-000315-26-SKF.Hoffmann-La Roche Ltd.2,000
Active, not recruiting
Not Applicable
First-line Bevacizumab and Chemotherapy in Metastatic Cancer of the Colon or Rectum. An Expanded Access Program. - First BEATMetastatic cancer of the colon or rectum.
EUCTR2004-000315-26-HUF. Hoffmann-La Roche Ltd.2,000
Active, not recruiting
Phase 1
First-line Bevacizumab and Chemotherapy in Metastatic Cancer of the Colon or Rectum.Metastatic cancer of the colon or rectum.Therapeutic area: Diseases [C] - Cancer [C04]
EUCTR2004-000315-26-ESF. Hoffmann-La Roche Ltd.2,000
Not yet recruiting
Phase 3
Bevacizumab-based Chemotherapy Adapted to Bevacizumab Pharmacokinetics in 1st-line TreatmentUnresectable Metastatic Colorectal Cancer
NCT06642844University Hospital, Tours244